In the early days of cochlear implantation (CI) surgery when the types of electrodes were limited and the etiology of sensorineural hearing loss (SNHL) was not well understood, the one-size-fits-all approach to CI held true like all other fields. However, in the era of personalized medicine, there have been attempts to associate CI performance with etiology of SNHL and to establish customized surgical techniques that can maximize performance according to individual cochlear dimensions. Personalized genomic-driven assessment of CI candidates and better understanding of genotype-phenotype correlations could provide clinically applicable diagnostic and prognostic information about questions such as who, how, and when to implant. Rigorous and strategic imaging assessments also provide a better insight into anatomic etiology of SNHL and cochlear dimensions, leading to individualized surgical techniques to augment CI outcome. Further, precision medicine approach to CI is not necessarily limited to preoperative planning but can be extended to either intraoperative electrode positioning or even decision of a timing of initial switch-on. In this review, we will discuss the implications of personalized diagnosis (both genetic and nongenetic) on planning and performance of CI in prelingual and postlingual SNHL.